Dr Ros Wilson Conducting an intensive, well-delivered roadshow that takes would-be investors right back to the beginning and explains why a successful trial outcome would unlock so much value.
A successful trial outcome possibly means:
1. A partner to fund phase 3 Venus leg ulcer trial on very favourable terms
2. A partner to fund the phase 2 ready-to-go Diabetic foot ulcer study on very favourable terms
3.Winning CE Mark approval to treat VLUs, once the application is submitted and approved (and the necessary remaining work that needs to be done to submit the application is done...hopefully FTT is doing this now, it probably ly not)
4. Possible interest in the corneal wound application
Or
5. Maybe a takeover bid for the company.
FTT's trial is a ghastly binary event proposition, but should the trial succeeds, tons of value is released.
this is the story FTT needs to communicate to would-be investors.
Ros Wilson's primary task up until now has been to recruit those damn patients. Now her primary task is to sell the story to investors. should the trial succeed, her primary task will be to sell the story to would- be partners and buyers of company.
When you consider how important communication is, it beats me why companies don’t spend more money getting professional help with their communication tasks.
If Australia's Chief Scientist employs a speech writer, why not our ASX-listed companies?
I'm not saying Ros is bad; she's good, but when the stakes are so high, wouldn’t you get all the help you can afford?
FTT Price at posting:
5.7¢ Sentiment: Buy Disclosure: Held